The spirometer market is estimated to be valued at US$ 1,148.7 Mn or Mn in 2023 and is expected to exhibit a CAGR of 9.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Spirometer is a medical device used to measure lung function by measuring how much air a person can inhale and exhale. There are various types of spirometers such as table-top spirometers, handheld spirometers, and PC-based spirometers. Table-top spirometers are commonly used for clinical diagnosis and treatment, whereas handheld and PC-based spirometers are used for home monitoring. Spirometers are widely used for diagnosing and monitoring respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis.

Market Dynamics:
The spirometer market is witnessing significant growth owing to increasing prevalence of respiratory diseases across the globe. As per the World Health Organization (WHO), respiratory diseases claimed over 4 million lives in 2015 accounting for 6.7% of total deaths globally. According to the Centers for Disease Control and Prevention (CDC), in 2020, around 25 million adults were reported to have asthma in the U.S. This large patient pool drives the demand for spirometers. Additionally, adoption of wireless and portable handheld spirometers for home monitoring of respiratory diseases is expected to propel market growth over the forecast period. However, high cost of advanced spirometers remains a major challenge.

SWOT Analysis
Strength: Spirometer devices provide accurate and precise results for screening and diagnosing respiratory diseases such as asthma and COPD. They are portable and easy to use in clinical as well as home settings. The devices offer results digitally and can be integrated with EMR systems for telehealth and remote monitoring.

Weakness: Higher costs of sophisticated spirometer devices limit their adoption in certain regions and healthcare facilities. Lack of trained healthcare professionals to operate advanced spirometers and interpret the test results in some developing nations.

Opportunity: Rising global prevalence of respiratory diseases drives the demand for lung function tests. Untapped growth opportunities in emerging Asian and Latin American countries. Integration of spirometers with mobile health apps opens up new opportunities for home healthcare and telespirometry.

Threats: Reimbursement issues and budgetary constraints of healthcare systems pose challenges. Stringent regulations for new product approvals delay market entry of novel technologies. Trade barriers and import duties on medical devices affect pricing.

Key Takeaways
The global Spirometer Market Growth  is expected to witness high growth, exhibiting CAGR of 9.5% over the forecast period, due to increasing global incidence of respiratory disorders such as COPD and asthma.

Market size: The global spirometer market size was valued at US$ 1,148.7 Mn in 2023 and is projected to reach over US$ 2,130 Mn by 2030.

Regional analysis: North America currently dominates the global market led by the US owing to high healthcare spending and supportive reimbursement structure for respiratory diagnostic tests. Asia Pacific is poised to register fastest growth over the next few years led by expanding patient pool, improving access to care, and rising healthcare investments in countries such as India and China.

Key players: Key players operating in the spirometer market are Koninklijke Philips N.V., SCHILLER, Midmark Corporation, Smiths Medical, Vyaire Medical, Inc., SDI Diagnostics, Nihon Kohden Corporation, COSMED srl, Fukuda Sangyo Co. Ltd., Medicare Systems, MGC Diagnostics Corporation, LabTech, Vitalograph, Futuremed, Geratherm Medical AG, Guangzhou Medsinglong Medical Equipment Co., Ltd, Aluna, and Welch Allyn.

For more insights, read- https://cmiinfonest.blogspot.com/2023/12/wearable-spirometers-is-fastest-growing.html